Pfizer Inc (NYSE:PFE) shares, rose in value on Wednesday, June 18, with the stock price down by -0.50% to the previous day’s close as strong demand from buyers drove the stock to $23.88.
Actively observing the price movement in the last trading, the stock closed the session at $24.00, falling within a range of $23.77 and $24.08. The value of beta (5-year monthly) was 0.491 whereas the PE ratio was 17.31 over 12-month period. Referring to stock’s 52-week performance, its high was $31.54, and the low was $20.92. On the whole, PFE has fluctuated by 3.83% over the past month.
With the market capitalization of Pfizer Inc currently standing at about $135.77 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-29. The company’s Forward Dividend Ratio is 1.70, with its dividend yield at 7.12%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PFE’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PFE currently trading nearly 0.71% and 3.15% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.12, while the 7-day volatility ratio is showing 0.55% which for the 30-day chart, stands at 1.27%. Furthermore, Pfizer Inc (PFE)’s beta value is 0.54, and its average true range (ATR) is 0.48.
A comparison of Pfizer Inc (PFE) with its peers suggests the former has fared considerably weaker in the market. PFE showed an intraday change of -0.50% in last session, and over the past year, it shrunk by -13.26%%.
Data on historical trading for Pfizer Inc (NYSE:PFE) indicates that the trading volumes over the past 10 days have averaged 38.66 and over the past 3 months, they’ve averaged 52.40 million. According to company’s latest data on outstanding shares, there are 5.68 billion shares outstanding.
Nearly 0.18% of Pfizer Inc’s shares belong to company insiders and institutional investors own 67.07% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 104.99 million shares as on 2025-05-30, resulting in a short ratio of 2.27. According to the data, the short interest in Pfizer Inc (PFE) stood at 185.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 115.16 million. The stock has fallen by -9.99% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PFE stock heading into the next quarter.
